Anticoagulation-associated adverse drug events

American Journal of Medicine

Volumn 124, Issue 12, 2011, Pages 1136-1142

  Piazza, Gregory ^a   Nguyen, Thanh Nha ^a   Cios, Deborah ^a   Labreche, Matthew ^a   Hohlfelder, Benjamin ^a   Fanikos, John ^a   Fiumara, Karen ^a   Goldhaber, Samuel Z ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Adverse drug events; Adverse drug reactions; Anticoagulation; Medication errors

Indexed keywords

ANTICOAGULANT AGENT; ARGATROBAN; FONDAPARINUX; HEPARIN; HIRULOG; LEPIRUDIN; LOW MOLECULAR WEIGHT HEPARIN; WARFARIN;

ADULT; ADVERSE DRUG REACTION; AGED; ANTICOAGULATION; ARTICLE; BLEEDING; BLOOD CLOTTING; COST BENEFIT ANALYSIS; DRUG SURVEILLANCE PROGRAM; FEMALE; HOSPITALIZATION COST; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICATION ERROR; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SIDE EFFECT; THROMBOCYTOPENIA; UNSPECIFIED SIDE EFFECT;

ADVERSE DRUG REACTION REPORTING SYSTEMS; AGED; ANTICOAGULANTS; DRUG TOXICITY; FEMALE; HUMANS; INPATIENTS; MALE; MEDICATION ERRORS; MIDDLE AGED; RISK FACTORS;

EID: 81855220395     PISSN: 00029343     EISSN: 15557162     Source Type: Journal    
DOI: 10.1016/j.amjmed.2011.06.009     Document Type: Article

References (23)

1. R. Zaidenstein, S. Eyal, and S. Efrati Adverse drug events in hospitalized patients treated with cardiovascular drugs and anticoagulants Pharmacoepidemiol Drug Saf 11 2002 235 238 (Pubitemid 34537530)
2. J.B. Silverman, C.D. Stapinski, and W.W. Churchill Multifaceted approach to reducing preventable adverse drug events Am J Health Syst Pharm 60 2003 582 586 (Pubitemid 36752889)
3. G. Piazza, and S.Z. Goldhaber Computerized decision support for the cardiovascular clinician: applications for venous thromboembolism prevention and beyond Circulation 120 2009 1133 1137
4. T. Morimoto, M. Sakuma, and K. Matsui Incidence of adverse drug events and medication errors in Japan: the JADE Study J Gen Intern Med 26 2010 148 153
5. B.L. Hug, D.J. Witkowski, and C.M. Sox Adverse drug event rates in six community hospitals and the potential impact of computerized physician order entry for prevention J Gen Intern Med 25 2009 31 38
6. D.C. Classen, L. Jaser, and D.S. Budnitz Adverse drug events among hospitalized Medicare patients: epidemiology and national estimates from a new approach to surveillance Jt Comm J Qual Patient Saf 36 2010 12 21
7. D.W. Bates, D.J. Cullen, and N. Laird Incidence of adverse drug events and potential adverse drug events Implications for prevention. ADE Prevention Study Group JAMA 274 1995 29 34
8. E.G. Poon, C.A. Keohane, and C.S. Yoon Effect of bar-code technology on the safety of medication administration N Engl J Med 362 2010 1698 1707
9. E.G. Poon, J.L. Cina, and W. Churchill Medication dispensing errors and potential adverse drug events before and after implementing bar code technology in the pharmacy Ann Intern Med 145 2006 426 434 (Pubitemid 46768573)
10. L.L. Leape, D.W. Bates, and D.J. Cullen Systems analysis of adverse drug events ADE Prevention Study Group JAMA 274 1995 35 43
11. M.C. Grissinger, R.W. Hicks, and M.A. Keroack Harmful medication errors involving unfractionated and low-molecular-weight heparin in three patient safety reporting programs Jt Comm J Qual Patient Saf 36 2010 195 202
12. J. Fanikos, C. Stapinski, and S. Koo Medication errors associated with anticoagulant therapy in the hospital Am J Cardiol 94 2004 532 535 (Pubitemid 39120014)
13. D.W. Bates, N. Spell, and D.J. Cullen The costs of adverse drug events in hospitalized patients Adverse Drug Events Prevention Study Group JAMA 277 1997 307 311 (Pubitemid 27045011)
14. J. Fanikos, J.L. Cina, and S. Baroletti Adverse drug events in hospitalized cardiac patients Am J Cardiol 100 2007 1465 1469 (Pubitemid 47576029)
15. J.T. Hanlon, C.F. Pieper, and E.R. Hajjar Incidence and predictors of all and preventable adverse drug reactions in frail elderly persons after hospital stay J Gerontol A Biol Sci Med Sci 61 2006 511 515 (Pubitemid 43794712)
16. E.R. Hajjar, J.T. Hanlon, and M.B. Artz Adverse drug reaction risk factors in older outpatients Am J Geriatr Pharmacother 1 2003 82 89 (Pubitemid 40410978)
17. J.R. Nebeker, P. Barach, and M.H. Samore Clarifying adverse drug events: a clinician's guide to terminology, documentation, and reporting Ann Intern Med 140 2004 795 801 (Pubitemid 38623529)
18. An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction The GUSTO investigators N Engl J Med 329 1993 673 682
19. J.W. Eikelboom, and J.I. Weitz New anticoagulants Circulation 121 2010 1523 1532
20. R.A. Hayward, and T.P. Hofer Estimating hospital deaths due to medical errors: preventability is in the eye of the reviewer JAMA 286 2001 415 420 (Pubitemid 32681483)
21. H.R. Jennings, E.C. Miller, and T.S. Williams Reducing anticoagulant medication adverse vents and avoidable patient harm Jt Comm J Qual Patient Saf 34 2008 196 200
22. M.H. Eckman, H.J. Levine, and S.G. Pauker Making decisions about antithrombotic therapy in heart disease Decision analytic and cost-effectiveness issues Chest 108 1995 457S 470S
23. J.S. Alpert Are data from clinical registries of any value? Eur Heart J 21 2000 1399 1401 (Pubitemid 30636318)